Koetsveld, J.

patient response t-cell vaccine study vaccination assay t-cell responses trial antigen elispot interruption infection control count value treatment t-cell count therapy nef-specific t-cell responses dendritic t-cell counts number t cells treatment interruption analysis dc-based time points electroporated phase virus result proliferation peptide immunol antiretroviral hiv -1-infected patients antiretroviral therapy autologou immunotherapy nef-specific brussel hiv infection event dc-based elispot regression protein dc-based elispot assay proliferative vaccine-specific t-cell responses peptide-based elispot assay -1-infected ifn -γ production dendritic cells laboratory cart resumption hiv-infected patients method increase allard point disease sfu /million pbmcs cfse proliferation assays change regression analysis leukapheresi study entry hiv-specific vaccine antigens immunization nadir cd 4 17 patients plasma administration resumption immunodeficiency figure activation group